Stronger Vein Grafts. Better Outcomes.


Reinventing Vein Graft Strength for Lasting Success

Contact Us Today
A green light is coming out of a white cylinder.

The Durvena PTP System has received Breakthrough Designation from the FDA

Published Pre-Clinical Study

PTP reduces vein graft wall thickness, luminal diameter and reduces intimal hyperplasia.

Read More

Transformational PTP

Before and After

DurVena is commercializing a photochemical tissue passivation therapy (“PTP”) that strengthens venous tissue and improves long term vein graft patency.

A picture of a thick intimal hyperplasia control vein
A picture of a thin intimal hyperplasia ptp treated vein

Arterializing Veins for Long Term Durability – The DurVena Difference

400,000-450,000 Coronary Artery Bypass Graft (CABG) procedures are performed in the U.S. annually (~900,000 worldwide). The majority of those procedures (+75%) utilize harvested saphenous vein graphs (SVG). Structurally, veins are not designed to withstand arterial pressure. The vein grafts expand under the arterial pressure and are subject to reported degeneration and occlusion rates from 20-40% in the first year and as high as 50% at five years. SVG failure is associated with a significant increase in major adverse cardiovascular events (MACE), including death, myocardial infarction (MI), and the need for repeat revascularization.


*This image was taken from a GLP animal study conducted by Durvena

Scientific Innovation, Clinically Proven Results

Extensive preclinical studies show that PTP technology significantly strengthens vein grafts, reducing excessive expansion and lowering failure rates. Discover the science behind DurVena’s innovation and its impact on long-term surgical success.

A black and white icon of a microscope with a speech bubble.

Stronger Vein Grafts

DurVena’s PTP technology reinforces vein grafts, reducing expansion and making them more resistant to arterial pressure, leading to improved long-term success.

A black and white icon of a microscope with a speech bubble.

Clinically Proven Innovation

Backed by extensive research and peer-reviewed studies, PTP has been shown to decrease intimal hyperplasia by 50-70%, a key factor in graft failure.

A black and white icon of a microscope with a speech bubble.

Seamless Surgical Integration

PTP treatment is quick and non-invasive, easily integrating into existing graft preparation without additional incisions or modifications.